IRONBRIDGE CAPITAL MANAGEMENT LP - ISIS PHARMACEUTICALS INC ownership

ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 205 filers reported holding ISIS PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 1.66 and the average weighting 0.2%.

Quarter-by-quarter ownership
IRONBRIDGE CAPITAL MANAGEMENT LP ownership history of ISIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2015$4,599,000
-31.3%
113,773
-2.3%
0.18%
-10.4%
Q2 2015$6,699,000
-11.9%
116,403
-2.6%
0.20%
-7.4%
Q1 2015$7,607,000
-49.4%
119,473
-51.0%
0.22%
-48.3%
Q4 2014$15,043,000
+31.1%
243,653
-17.5%
0.42%
+37.7%
Q3 2014$11,471,000
+10.2%
295,413
-2.3%
0.30%
+19.6%
Q2 2014$10,412,000
-27.8%
302,243
-9.5%
0.26%
-18.8%
Q1 2014$14,423,000
+0.6%
333,799
-7.3%
0.31%
+2.6%
Q4 2013$14,343,000
+0.7%
360,020
-5.1%
0.31%
+1.3%
Q3 2013$14,242,000379,3760.30%
Other shareholders
ISIS PHARMACEUTICALS INC shareholders Q3 2013
NameSharesValueWeighting ↓
BB BIOTECH AG 7,202,585$270,385,00014.71%
DOWLING & YAHNKE LLC 675,798$25,369,0003.98%
GARRISON BRADFORD & ASSOCIATES INC 100,700$3,780,0003.87%
WILLIAM HARRIS INVESTORS INC 312,834$11,743,0003.67%
Meditor Group Ltd 490,000$18,395,0002.59%
AVALON CAPITAL MANAGEMENT 50,943$1,912,0001.89%
Orinda Asset Management LLC 14,665$551,0001.73%
PINNACLE ASSOCIATES LTD 2,064,760$77,511,0001.60%
PERKINS CAPITAL MANAGEMENT INC 52,850$1,984,0001.43%
NCM Capital Advisers, Inc. 24,950$937,0001.04%
View complete list of ISIS PHARMACEUTICALS INC shareholders